Beamr video compression achieves up to 50% improvement for AVs
WINSFORD, UK - Advanced Medical (TASE:BLWV) Solutions Group plc (AIM:AMS (VIE:AMS2)), a global leader in tissue-healing technologies, has announced the release of its Annual Report and Accounts for the year ended December 31, 2024, and the scheduling of its Annual General Meeting (AGM) for June 30, 2025. The documents have been distributed to shareholders and are accessible on the company’s website.
The upcoming AGM is set to take place at 11:00 a.m. at the offices of Investec (LON:INVP) Bank plc in London. Shareholders are provided with a proxy form and the Notice of AGM on the AMS website, ensuring they are informed about the meeting and can exercise their voting rights.
AMS, established in 1991, operates as an independent developer and manufacturer of innovative tissue-healing products aimed at improving patient outcomes and offering cost-effective solutions for payers. The company’s product portfolio includes tissue adhesives, sutures, haemostats, fixation devices, and internal sealants marketed under various brands such as LiquiBand®, RESORBA®, and Seal-G®.
In addition to its surgical products, AMS provides a range of wound care dressings through its ActivHeal® brand and other white label arrangements. The company’s global reach extends through a network of partners and distributors, as well as direct sales forces in multiple countries.
AMS has expanded its operations through several acquisitions since 2019, including companies specializing in surgical biomaterials, tissue adhesives, and specialty surgical sutures. The group’s manufacturing facilities are located across the UK, Germany, France, the Netherlands, Thailand, India, the Czech Republic, and Israel, with R&D innovation hubs in the UK, Ireland, Germany, France, and Israel.
The company employs over 1,500 people and continues to focus on developing high-quality surgical and wound care products to meet the evolving needs of healthcare providers and patients worldwide.
This news is based on a press release statement issued by Advanced Medical Solutions Group plc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.